Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
74 1.4% |
 |
Gilead SciencesGILD |
54 1.9% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Jun 2025 | 51 | |
| May 2025 | 51 | |
| Apr 2025 | 51 | |
| Mar 2025 | 47 | |
| Feb 2025 | 51 |
How do employees feel about the future at Corcept Therapeutics?
The Business Outlook at Corcept Therapeutics is neutral, according to employees. The average rating, aggregated from the top review sites in the US, of 51 out of 100 is decent.
Analyzing Business Outlook, how is Corcept Therapeutics performing compared to its industry peers?
Compared to its peers, Corcept Therapeutics ranks in the 51st percentile when it comes to Business Outlook.
How has the business outlook at Corcept Therapeutics changed over the last couple of months
There has been no meaningful change in the business outlook amongst employees at Corcept Therapeutics.
Why is it important to track the business outlook at Corcept Therapeutics?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at Corcept Therapeutics.
